News

POET Technologies to Delist from TSX Venture Exchange Soon

POET Technologies to Delist from TSX Venture Exchange Soon

POET Technologies Announces Voluntary Delisting Plans

POET Technologies Inc. (NASDAQ: POET), a pioneer in developing advanced photonic solutions, has made an important announcement regarding its future on the TSX Venture Exchange (TSXV). The company has decided to voluntarily delist its common shares from the TSXV, moving forward with a strategic focus that aligns with its operational and financial goals. This decision comes after careful deliberation by the company's board of directors, which has noted that the majority of POET's trading activity occurs on the Nasdaq.

Reasons Behind the Delisting

As the trading volume on the TSXV has consistently lagged behind that of the Nasdaq, POET Technologies has determined that keeping the TSXV listing is no longer critical to its capital markets strategy. This strategic shift allows POET to streamline its operations while ensuring that shareholders have ample opportunities to trade their shares on a highly active market like the Nasdaq. Importantly, the company will not require security holder approval for this delisting due to the existing alternative market available on the Nasdaq.

Continuing Operations in Canada

Despite the voluntary delisting, POET Technologies will maintain its status as a 'reporting issuer' in Canada. This means the company will continue to provide comprehensive and regular disclosures in accordance with Canadian securities laws. The company's commitment to transparency remains firm, ensuring that all stakeholders are kept informed of its activities and developments.

Trading on Nasdaq

Shareholders are encouraged to contact their brokers to understand how they can trade POET's shares on the Nasdaq, where trading volume is significantly higher. Many Canadian brokers, including discount and online options, facilitate transactions for stocks listed on the Nasdaq, providing flexibility for POET shareholders who wish to buy or sell their shares.

About POET Technologies Inc.

POET Technologies Inc. is at the forefront of developing photonic integration solutions aimed at revolutionizing the artificial intelligence and data center markets. The cornerstone of its innovation is the POET Optical Interposer™, a proprietary technology that allows for the integration of electronic and photonic components into a single chip, offering enhanced performance, reduced power consumption, and lower production costs. With the ability to deliver high-speed optical engines and modules, POET Technologies is positioning itself as a key player in AI and data center solutions.

Future Outlook for POET Technologies

As the demand for high-performance computing and data transfer continues to surge, POET is strategically pivoting to meet the needs of evolving markets. The company focuses on expanding its offerings to include optical engines, modules, and innovative light sources, enabling efficient chip-to-chip communication within AI systems. The integration of advanced photonics not only addresses latency issues but also positions POET's technology as essential in 5G networks and other cutting-edge applications.

Moreover, POET's developments are set to make significant contributions to machine-to-machine communication and edge computing technologies, which are crucial for the future of autonomous vehicles and other advanced applications.

Contact Information

For inquiries, you may contact:

Media Relations Contact:
Adrian Brijbassi
Email: Adrian.brijbassi@poet.tech

Company Contact:
Thomas R. Mika, EVP & CFO
Email: tm@poet.tech

Frequently Asked Questions

What is the reason for POET Technologies' delisting from TSXV?

POET Technologies is delisting from TSXV due to low trading volume there, focusing instead on the more active Nasdaq market.

Will shareholders still be able to trade their shares after the delisting?

Yes, shareholders can trade their shares on the Nasdaq, where there is significantly more trading activity.

What is POET Technologies known for?

POET Technologies specializes in developing photonic integration solutions, primarily using its proprietary Optical Interposer™ technology.

Is POET still a reporting issuer in Canada after the delisting?

Yes, POET will maintain its status as a reporting issuer in Canada and will continue to comply with Canadian securities regulations.

How can shareholders trade POET shares on Nasdaq?

Shareholders should contact their brokers to confirm procedures for trading POET shares on the Nasdaq.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Western Microsurgical Expands Through Strategic Acquisitions

Updated Category News Views 67

Western Microsurgical's Bold Moves Western Microsurgical (WMS) is out here making waves, pulling off some serious strategic plays with the acquisitions of Q Surgical and Proficient Surgical. Now, this ain't some fly-by-night decision—this is about securing territory and leveling up their game in surgical microscopes and operating room supplies. With a footprint that'll...

Continue Reading
U.S.-Saudi Business Leaders Eye Growth Amid Challenges

Updated Category News Views 107

Revitalizing a Strategic Partnership Monday's meeting of the U.S.-Saudi Business Council wasn't just another gathering of suits; it was about re-kindling the investment flame between these two economic giants. Chaired by powerhouses Lubna Olayan and Jane Fraser, this wasn't a mere photo op. It was a call to arms in a landscape riddled with hurdles but bursting with...

Continue Reading
DexCom Faces Scrutiny: Fiduciary Breach Questioned

Updated Category News Views 190

Is DexCom’s Leadership Under The Gun? Here's the scoop, folks—DexCom, Inc. (NASDAQ:DXCM) has been hit with some serious questions recently. Nothing like a potential fiduciary breach to shake things up. October 27, 2026, is when the news broke, with Halper Sadeh LLC taking the reins on this investigation. They’re poking around to see if DexCom’s top dogs stumbled...

Continue Reading
North Fork Mono Casino Opens: A $750 Million Bet

Updated Category News Views 57

A New Spin in Madera Cue the fanfare, folks! The North Fork Mono Casino just threw open its doors earlier than expected today, marking a hefty $750 million wager right in the heart of California's Central Valley. It's a big deal managed by Station Casinos, part of Red Rock Resorts, Inc. (NASDAQ: RRR)—teaming up with the North Fork Rancheria of Mono Indians for a...

Continue Reading
DICK'S Sporting Goods Faces Investor Lawsuit Deadline Looms

Updated Category News Views 23

A Rough Tumble for DICK'S Sporting Goods Let's cut to the chase: DICK'S Sporting Goods, Inc. (NYSE:DKS) just took a nosedive. We're talking a hard 30.68% fall on the stock, plummeting to $124.31 a share as of August 25, 2026. Now, if you were caught up in this whirlwind as an investor, you'd be forgiven for having a few choice words for the powers that be over at DICK'S....

Continue Reading
Noma Hits Fortune Cyber 60 with AI Security Success

Updated Category News Views 13

Celebrating an AI Security Standout Well, look at that, Noma's found itself on the Fortune Cyber 60 list for 2026-2027. This listing isn't just some vanity metric. We’re talking about getting the nod from heavyweights like Lightspeed Venture Partners and Amazon Web Services. It recognizes them among 60 pivotal, venture-backed cybersecurity players, and sure, it’s in...

Continue Reading
oToBrite Unveils Avant-Garde Robotics Vision Tech at ROBOTWORLD

Updated Category News Views 57

An Eye on the Future: oToBrite's Bold Vision for Robotics Strolling down the aisles at ROBOTWORLD 2026, there's a palpable energy buzzing around oToBrite's booth. These folks are showcasing vision technology that's not just about snapping slick photos—it's about reshaping how machines see the world. And, let me tell you, if there’s one place to flaunt cutting-edge...

Continue Reading
Bank Leumi Q3 Earnings Preview: Key Dates & Insights

Updated Category News Views 61

A Closer Look at Bank Leumi's Upcoming Q3 Release Take a seat, folks. Bank Leumi’s gearing up to spill the beans on their Third Quarter 2026 earnings come November 17th. If you’re in the financial world, you might want to mark your calendar because these reports tend to shake things up. You know how these go - numbers rolling out, market responses, and plenty of...

Continue Reading
Jiahui's Bold Leap into Global Cell Therapy Market

Updated Category News Views 66

Jiahui's International Cell Therapy Center: A New Era Jiahui International Hospital is shaking up the healthcare scene with its fresh International Cell Therapy Center, diving headfirst into the cutting-edge world of CAR-T treatments. It's not every day you see this kind of bold move, especially from a player aiming to extend their reach both in China and abroad. Let's...

Continue Reading
CELSET Unveils SOLTOX: Expanding in Global Markets

Updated Category News Views 19

New Contender in the Global Botulinum Toxin Arena Launching a fresh player onto the international stage, CELSET INC. from Seoul throws down with SOLTOX, their own botulinum toxin Type A brand. This ain't your run-of-the-mill roll-out; it's another notch for Korean biotech trying to snag a piece of global market action. A Look at SOLTOX's Technical Makeup We’re talking...

Continue Reading